Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Torrent Pharmaceuticals LtdTorrent Pharmaceuticals Ltd
VS
Eli Lilly and CompanyEli Lilly and Company
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd, Ahmedabad, 380015, IN

Last Update: 02/04/2026

View Profile
Between 750 and 799
http://www.torrentpharma.com
789/1000Fair

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:11,552
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Eli Lilly and Company

Eli Lilly and Company

Lilly Corporate Center, Indianapolis, Indiana, US, 46285

Last Update: 19/07/2026

View Profile
Between 800 and 849
http://www.lilly.com/
843/1000Good

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power o...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:53,748
Subsidiaries:19
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Eli Lilly and Company

Eli Lilly and Company

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Torrent Pharmaceuticals Ltd in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eli Lilly and Company in 2026.

Incidents

Incident History - Torrent Pharmaceuticals Ltd (X = Date, Y = Severity)

Torrent Pharmaceuticals Ltd cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Eli Lilly and Company (X = Date, Y = Severity)

Eli Lilly and Company cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Incidents
No explicit notable incidents reported.
Eli Lilly and Company

Eli Lilly and Company

Incidents
No explicit notable incidents reported.

FAQ

Between Torrent Pharmaceuticals Ltd company and Eli Lilly and Company company, which one has the best AI Cybersecurity Score ?
Between Torrent Pharmaceuticals Ltd company and Eli Lilly and Company company, which one has experienced more cyber incidents in the past ?
Between Torrent Pharmaceuticals Ltd company and Eli Lilly and Company company, which one has experienced more cyber incidents this year ?
Between Torrent Pharmaceuticals Ltd company and Eli Lilly and Company company, which one has experienced at least one ransomware attack ?
Between Torrent Pharmaceuticals Ltd company and Eli Lilly and Company company, which one has experienced at least one data breach ?
Between Torrent Pharmaceuticals Ltd company and Eli Lilly and Company company, which one has experienced at least one targeted cyberattack ?
Between Torrent Pharmaceuticals Ltd company and Eli Lilly and Company company, which one has experienced at least one vulnerability ?
Between Torrent Pharmaceuticals Ltd company and Eli Lilly and Company company, which one holds the most compliance certifications ?
Between Torrent Pharmaceuticals Ltd company and Eli Lilly and Company company, which one holds the fewest compliance certifications ?
Between Torrent Pharmaceuticals Ltd company and Eli Lilly and Company company, which one has the most subsidiaries ?
Between Torrent Pharmaceuticals Ltd company and Eli Lilly and Company company, which one has the largest number of employees ?
Between Torrent Pharmaceuticals Ltd and Eli Lilly and Company, which company holds both SOC 2 Type 1 certifications ?
Between Torrent Pharmaceuticals Ltd and Eli Lilly and Company, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Torrent Pharmaceuticals Ltd or Eli Lilly and Company ?
Which company is PCI DSS compliant - Torrent Pharmaceuticals Ltd or Eli Lilly and Company ?
Between Torrent Pharmaceuticals Ltd and Eli Lilly and Company, which company complies with HIPAA regulations for healthcare data ?
Between Torrent Pharmaceuticals Ltd and Eli Lilly and Company, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60455
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60439
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60373
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60372
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
3.9